Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes
- PMID: 9184377
- DOI: 10.1006/meth.1997.0462
Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes
Abstract
Strategies have been developed to characterize tumor antigens recognized by cytolytic T lymphocytes (CTL). We use a genetic approach based on the transfection of HLA genes and cDNA libraries in COS cells to isolate the gene producing the antigenic peptide. The tumor-specific expression of this gene can be evaluated by cDNA synthesis and quantitative PCR amplification. Transfection of fragments of the isolated gene allows the identification of the region encoding the antigenic peptide. Peptides are synthesized and tested for their ability to sensitize target cells to lysis by the CTL.
Similar articles
-
Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.Cancer Res. 1999 Nov 15;59(22):5785-92. Cancer Res. 1999. PMID: 10582700
-
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.J Immunol. 1999 Sep 1;163(5):2928-36. J Immunol. 1999. PMID: 10453041
-
Identification of genes encoding T cell defined tum- antigens.Princess Takamatsu Symp. 1988;19:255-63. Princess Takamatsu Symp. 1988. PMID: 3151988
-
Immunodominance across HLA polymorphism: implications for cancer immunotherapy.J Immunother. 1998 Jan;21(1):1-16. J Immunother. 1998. PMID: 9456431 Review.
-
Modulation of immune lysis of tumor cells by interferon.Biomembranes. 1983;11:313-39. Biomembranes. 1983. PMID: 6187384 Review. No abstract available.
Cited by
-
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.Cancer Immunol Immunother. 2009 Feb;58(2):271-80. doi: 10.1007/s00262-008-0551-0. Epub 2008 Jul 9. Cancer Immunol Immunother. 2009. PMID: 18612636 Free PMC article.
-
A novel strategy for the identification of antigens that are recognised by bovine MHC class I restricted cytotoxic T cells in a protozoan infection using reverse vaccinology.Immunome Res. 2007 Feb 9;3:2. doi: 10.1186/1745-7580-3-2. Immunome Res. 2007. PMID: 17291333 Free PMC article.
-
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer.Cancer Immunol Immunother. 2008 Aug;57(8):1125-36. doi: 10.1007/s00262-007-0442-9. Epub 2008 Jan 10. Cancer Immunol Immunother. 2008. PMID: 18188562 Free PMC article.
-
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.Cancer Immunol Immunother. 2007 Apr;56(4):515-26. doi: 10.1007/s00262-006-0204-0. Epub 2006 Jul 28. Cancer Immunol Immunother. 2007. PMID: 16874485 Free PMC article. Clinical Trial.
-
Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells.Br J Cancer. 2000 Feb;82(3):691-701. doi: 10.1054/bjoc.1999.0982. Br J Cancer. 2000. PMID: 10682684 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials